{"result": "(\"entity\"<|>CIE-11<|>ORGANIZATION<|>The CIE-11 is the International Classification of Diseases developed by the WHO, used globally to identify health trends and statistics.)\n##\n(\"entity\"<|>OMS<|>ORGANIZATION<|>The OMS, or World Health Organization, is an international public health agency responsible for coordinating health responses and setting health standards.)\n##\n(\"entity\"<|>Hembree WC<|>PERSON<|>Hembree WC is a medical professional who contributed to the clinical practice guideline for endocrine treatment of gender-dysphoric individuals.)\n##\n(\"entity\"<|>Cohen-Kettenis PT<|>PERSON<|>Cohen-Kettenis PT is a medical professional involved in the endocrine treatment guidelines for gender-dysphoric individuals.)\n##\n(\"entity\"<|>Gooren L<|>PERSON<|>Gooren L is a medical expert who co-authored the clinical practice guideline for the treatment of gender-dysphoric individuals.)\n##\n(\"entity\"<|>Hannema SE<|>PERSON<|>Hannema SE is a contributor to the clinical practice guideline for endocrine treatment of gender-dysphoric individuals.)\n##\n(\"entity\"<|>Meyer WJ<|>PERSON<|>Meyer WJ is a medical professional who participated in the development of the endocrine treatment guidelines for gender-dysphoric individuals.)\n##\n(\"entity\"<|>Murad MH<|>PERSON<|>Murad MH is a medical expert who co-authored the clinical practice guideline for endocrine treatment of gender-dysphoric individuals.)\n##\n(\"entity\"<|>Asamblea Mundial de la Salud<|>EVENT<|>The World Health Assembly is an event where global health policies are discussed and adopted, including the presentation of the CIE-11.)\n##\n(\"relationship\"<|>CIE-11<|>OMS<|>The CIE-11 is developed by the OMS to standardize health classifications globally<|>8)\n##\n(\"relationship\"<|>Hembree WC<|>CIE-11<|>Hembree WC contributed to the clinical practice guideline related to the CIE-11<|>7)\n##\n(\"relationship\"<|>Cohen-Kettenis PT<|>CIE-11<|>Cohen-Kettenis PT contributed to the clinical practice guideline related to the CIE-11<|>7)\n##\n(\"relationship\"<|>Gooren L<|>CIE-11<|>Gooren L contributed to the clinical practice guideline related to the CIE-11<|>7)\n##\n(\"relationship\"<|>Hannema SE<|>CIE-11<|>Hannema SE contributed to the clinical practice guideline related to the CIE-11<|>7)\n##\n(\"relationship\"<|>Meyer WJ<|>CIE-11<|>Meyer WJ contributed to the clinical practice guideline related to the CIE-11<|>7)\n##\n(\"relationship\"<|>Murad MH<|>CIE-11<|>Murad MH contributed to the clinical practice guideline related to the CIE-11<|>7)\n##\n(\"relationship\"<|>Asamblea Mundial de la Salud<|>CIE-11<|>The CIE-11 was presented at the World Health Assembly for adoption<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: visceral y la disminución de la grasa subcutánea asociada a insu-\n                                                                                                                                                        linorresistencia es perjudicial, por cuanto se asocia con                 el perfil del  síndrome metabólico\n                                                                                                                                                        (obesidad abdominal, dislipemia, HTA y alteraciones                  hidrocarbonadas), con mayor            morbi-\n                                                                                                                                                        mortalidad por enfermedad cardiovascular, agravado por el aumento de hematocrito. Es\n                                                                                                                                                        importante vigilar que el hematocrito no suba del 50%, sobre todo en pacientes con dosis\n                                                                                                                                                        altas de testosterona, y tener adecuadamente controlados todos los factores de riesgo car-\n                                                                                                                                                        diovascular, y tratarlos de forma adecuada.\n                                                                                                                                                        Estos pacientes están predispuestos a padecer apneas del sueño, si bien son necesarios\n                                                                                                                                                        trabajos a más largo plazo para conocer mejor sus consecuencias.\n\n\n\n340                                                                                                                                                                                                                                                                            341\n---\n                                                                                                                                                            GÓNADAS,               SÍNDROME POLIGLANDULAR                                                6\n                                                                                                                                                                                AUTOINMUNE Y MISCELÁNEA\n\n\n\n         Otros efectos adversos dermatológicos de la testosterona son el acné y la alopecia.                                         Muchas de estas personas desean que el nombre y el género con el que se identifican se\n         Por tanto, hay hacer un seguimiento tanto de los cambios físicos como de los posibles efec-                                 reconozcan legalmente y se             reflejen en los documentos           de  identidad    oficiales.  Además,\n         tos adversos clínicos y de laboratorio, con control de niveles hormonales cada 3-6 meses                                    muchas de ellas cambian su apariencia física, por ejemplo la forma de vestir, para afirmar\n         en el primer año y cada 6-12 meses posteriormente.                                                                          o expresar su identidad de género. Algunas personas trans, aunque no todas, se someten a\n                                                                                                                                     cirugía de afirmación de género, a tratamientos con hormonas o a ambas cosas.\n         La exploración y vigilancia mamaria y de citologías han de ser la de cualquier otra mujer, si no                            En definitiva, una transexual mujer (de hombre a mujer) se siente e identifica interiormente\n         se ha llevado a cabo mastectomía o histerectomía.                                                                           como mujer, aunque se sabe anatómicamente varón, en consecuencia, realiza todos los\n         Es recomendable hacer controles de densitometría ósea cuando haya riesgo de osteoporo-                                      esfuerzos posibles para que su cuerpo se adecue a esta identidad.\n         sis, sobre todo si se suspende la terapia hormonal tras la gonadectomía.                                                    La Clasificación Internacional de Enfermedades (CIE) es el instrumento elaborado                             por la\n         Referencias:                                                                                                                OMS, utilizado      internacionalmente para identificar tendencias                y estadísticas de      salud en\n         • Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine Treatment of Gender-Dysphoric/  todo el mundo. La CIE-11 se presentó en la Asamblea Mundial de la Salud de mayo de 2019\n           Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab [Internet].\n           2017;102(11):3869-903. https://doi.org/10.1210/jc.2017-01658                                                              para su adopción por los Estados Miembros, y entrará en vigor el 1 de enero de 2022. La\n         • Narasimhan S, Safer JD. Hormone Therapy for Transgender Men. Clin Plast Surg. 2018;45(3):319-22.                          nueva CIE también contiene nuevos capítulos, uno de los cuales versa sobre salud sexual,\n                                                                                                                                     en el que se incluyen afecciones que anteriormente estaban clasificadas en otras seccio-\n         Con respecto a una mujer adulta transexual (transexual de hombre a mujer) señale                                            nes. Por ejemplo, la incongruencia de género se incluía dentro de las afecciones mentales, y\n     21                                                                                                                              ahora pasará a este nuevo capítulo. Hasta su entrada en vigor, seguimos usando la CIE-10.\n         la opción falsa:                                                                                                            La CIE-10 define tres diferentes trastornos de la identidad sexual: Trastorno de la identidad\n         A. Para poder considerar a alguien como transexual tiene que cumplir tres criterios (CIE-10):                               sexual de la infancia, travestismo de rol doble y transexualismo, que el DSM-IVTR recogía\n             a) el deseo de vivir y ser aceptado como un miembro el sexo opuesto, generalmente                                       dentro de una misma categoría, denominada trastorno de la identidad sexual.\n             acompañado por el deseo de hacer que el cuerpo concuerde lo más posible con el del                                      F64.0 Transexualismo: según esta versión, la transexualidad tiene tres criterios:\n             sexo preferido; b) la identidad transexual ha estado presente persistentemente durante\n             por lo menos 2 años, y c) la entidad no es un\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}